Please Wait...

Barbara Clendenen

Main profile

Barbara Clendenen, MBA
Barbara Clendenen, MBA
Director, Business Development, Drug Safety and Regulatory

Barbara Clendenen, MBA, designs Pharmacovigilance and Regulatory solutions that increase compliance and reduce risk for life science organizations. She has over 20 years of experience blending both science and business expertise to assist pharmaceutical, biotech, medical device, and CRO clients in meeting research and post marketing goals. She began her career as a research scientist in Immunology and Oncology.  Since 1998, she has held pivotal roles in business development and sales management within the scientific and clinical research industry for Becton Dickinson, Fisher Scientific, and Bio-Rad. Prior to joining Bioclinica in 2015, she led the Business Development Team at Quorum Review IRB, developed the organization's entry into the hospital and AMC market, and participated in CIRB (Consortium of Independent Review Boards). Barbara graduated from University of Washington with a Bachelor's degree in Microbiology and from Seattle University with a Master's in Business Administration.

Blogs

The electronic common technical document (eCTD) is an interface for the pharmaceutical industry to transfer regulatory information based on the Common Technical Document (CTD) format, which is an agreed common format for applications that will be acceptable in all three ICH-Regions (US, EU & Japan) and other countries.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @eClinical_Jen: FREE on-demand webinars from @bioclinica on EDC, Imaging, RBM, and Clinical Trial Management. Tell them I sent you! http…
bioclinica (Yesterday)
Excited to host NJ Lt. Gov. Kim Guadagno, clients, partners 9/28 in Princeton! In the area? Join us ! RSVP… https://t.co/PrfyxvasGb
bioclinica (3 days ago)
Be sure to follow #ThankAScientist all week to thank researchers for the work they do! https://t.co/Sfi9mmHbSk… https://t.co/y9ZhBXsIzu
bioclinica (3 days ago)
Cardiovascular imaging use is growing in non-cardiovascular areas #ClinicalTrials. See where in Tim Crowe's blog… https://t.co/dYjPBC0Wtn
bioclinica (3 days ago)
RT @Xtalks: Cardiovascular Safety in #Biopharmaceutical Product Development - From QT Prolongation and Beyond @bioclinica https://t.co/mCk1…
bioclinica (3 days ago)
RT @Xtalks: How Innovations in Data Visualization Are Accelerating Data Cleaning and Improving Quality @bioclinica https://t.co/vfLU8pS9Rd
bioclinica (3 days ago)

Latest Blogs: